VICTR

April 19, 2021

VUMC aids national effort to repurpose drugs for COVID-19

Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.

By Bill Snyder

The study team includes (seated, from left) Adrienne Baughman, CCRP; Bob McClellan; Wesley Self, MD, MPH; Christina Kampe, CCRP; (standing, from left) Rendie McHenry; Bo Stubblefield, MD; Jon Casey, MD, MSCI; Todd Rice, MD, MSc; Natasha Halasa, MD, MPH; Jakea Johnson, MPH; Jim Chappell, MD, PhD; Carlos Grijalva, MD, MPH; and Kelsey Womack, PhD. Not pictured are Julia Rhoads, PhD; Chris Lindsell, PhD; Keipp Talbot; MD, MPH; and Kimberly Hart, MA. (photo by Donn Jones)

March 2, 2021

Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization

As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.

By Kristin Smart

October 29, 2020

Self named VP for Clinical Research Networks and Strategy

Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.

By VUMC News and Communications

July 30, 2020

Hartmann named first Vice President for Research Integration

Katherine Hartmann, MD, PhD, Associate Dean for Clinical and Translational Scientist Development, has been named Vice President for Research Integration for Vanderbilt University Medical Center.

By Leigh MacMillan

July 23, 2020

Rice named to new leadership role for VICTR operations

Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).